What changed in this filing

/stocks — the workspaceLOADING

Item 9A. Controls and Procedures

2020-03-30 compared with 2019-04-01 · 557 added, 939 removed, 102 unchanged (94% of the section changed)

Controls and Procedures

(a) Evaluation of Disclosure and

Control Procedures

Based on his evaluation as of the end of

the period covered by this Annual Report on Form 10-K, our principal executive officer and principal financial officer has concluded

that our disclosure controls and procedures (as defined in Rules 13a-15(c) and 15d-15(e) under the Exchange Act) are not effective

to ensure that information required to be disclosed by us in report that we file or submit under the Exchange Act is recorded,

processed, summarized and reported within the time periods specified in the U.S.

Securities and Exchange Commission’s rules

and forms and to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange

Act is accumulated and communicated to our management, including our chief executive officer, as appropriate to allow timely decisions

regarding required disclosure.

Evaluation of Disclosure and Control Procedures

on an evaluation as of the end of the period covered by this Annual Report on Form 10-K, our principal executive and financial

officer has concluded that our disclosure controls and procedures (as defined in Rules 13a-15(c) and 15d-15(e) under the Exchange

Act) are not effective to ensure that information required to be disclosed by us in report that we file or submit under the Exchange

Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and to

ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated

and communicated to our management, including our chief executive officer, as appropriate to allow timely decisions regarding

required disclosure.

(b) Management’s

Report on Internal Control over Financial Reporting

This Company’s management is responsible

for establishing and maintaining internal controls over financial reporting and disclosure controls.

Internal Control Over Financial

Reporting is a process designed by, or under the supervision of, the Company’s principal executive and principal financial

officer, or persons performing similar functions, and effected by the board of directors, management and other personnel, to provide

reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external

purposes in accordance with generally accepted accounting principles and includes those policies and procedures that:

Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the issuer;

Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the issuer are being made only in accordance with authorizations of management and directors of the registrant;

Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the issuer’s assets that could have a material effect on the financial statements.

Disclosure controls and procedures are

designed to ensure that information required to be disclosed in reports filed under the Securities Exchange Act of 1934, as amended,

is appropriately recorded, processed, summarized and reported within the specified time periods.

Management has conducted an evaluation

of the effectiveness of our internal control over financial reporting as of December 31, 2018, based on the framework established

in Internal Control-Integrated Framework-2013 issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”).

Based on this assessment, management concluded

that as of the period covered by this Annual Report on Form 10-K, it had material weaknesses in its internal control procedures.

As of period covered by this Annual Report

on Form 10-K, we have concluded that our internal control over financial reporting was not effective.

The Company’s assessment

identified certain material weaknesses which are set forth below:

Functional Controls and Segregation

Because of the Company’s limited

resources, there are limited controls over information processing.

There is an inadequate segregation of duties

consistent with control objectives.

Our Company’s management is composed of a small number of individuals resulting in a

situation where limitations on segregation of duties exist.

In order to remedy this situation we would need to hire additional

staff to provide greater segregation of duties.

Currently, it is not feasible to hire additional staff to obtain optimal segregation

Management will reassess this matter in the following year to determine whether improvement in segregation of duty is

Accordingly, as the result of identifying

the above material weakness we have concluded that these control deficiencies resulted in a reasonable possibility that a material

misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis by the Company’s

internal controls.

Management believes that the material weaknesses

set forth above were the result of the scale of our operations and are intrinsic to our small size.

Management believes these weaknesses

did not have a material effect on our financial results and intends to take remedial actions upon receiving funding for the Company’s

business operations.

This annual report does not include an

attestation report of our registered public accounting firm regarding internal control over financial reporting.

Management’s

report was not subject to attestation by our registered public accounting firm pursuant to temporary rules of the SEC that permit

the Company to provide only management’s report herein.

in Internal Control over Financial Reporting

There were no

changes in our internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act, during

our most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal

Company’s management is responsible for establishing and maintaining internal controls over financial reporting and disclosure

Internal Control Over Financial Reporting is a process designed by, or under the supervision of, the Company’s

principal executive and financial officer, or persons performing similar functions, and effected by the board of directors, management

and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial

statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures

to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of

the assets of the issuer;

reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance

with generally accepted accounting principles, and that receipts and expenditures of the issuer are being made only in accordance

with authorizations of management and directors of the registrant;

reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the issuer’s

assets that could have a material effect on the financial statements.

controls and procedures are designed to ensure that information required to be disclosed in reports filed under the Securities

Exchange is appropriately recorded, processed, summarized and reported within the specified time periods.

has conducted an evaluation of the effectiveness of our internal control over financial reporting as of December 31, 2019, based

on the framework established in Internal Control-Integrated Framework-2013 issued by the Committee of Sponsoring Organizations

of the Treadway Commission (“COSO”).

of period covered by this Annual Report on Form 10-K, we have concluded that our internal control over financial reporting was

not effective.

The Company’s assessment identified certain material weaknesses which are set forth below:

Controls and Segregation of Duties

of the Company’s limited resources, there are limited controls over information processing.

is an inadequate segregation of duties consistent with control objectives.

Our Company’s management is composed of a small

number of individuals resulting in a situation where limitations on segregation of duties exist.

In order to remedy this situation,

we would need to hire additional staff to provide greater segregation of duties.

Currently, it is not feasible to hire additional

staff to obtain optimal segregation of duties.

Management will reassess this matter in the following year to determine whether

improvement in segregation of duty is feasible.

as the result of identifying the above material weakness we have concluded that these control deficiencies resulted in a reasonable

possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a

timely basis by the Company’s internal controls.

believes that the material weaknesses set forth above were the result of the scale of our operations and are intrinsic to our

Management believes these weaknesses did not have a material effect on our financial results and intends to take remedial

actions upon receiving funding for the Company’s business operations.

Annual Report on Form 10-K does not include an attestation report of our registered public accounting firm regarding internal

control over financial reporting.

Other Information.

Directors, Executive Officers

and Corporate Governance.

Directors and Executive Officers

The following table and biographical summaries

set forth information, including principal occupation and business experience, about our directors and executive officers at April

Jeremy Frommer(1)(2)

Chief Executive Officer, Director

Rick Schwartz(1)(4)

Former President

Leonard Schiller(2)

Andrew Taffin(3)

Justin Maury (4)

(1) Effective February 5, 2016,

Jeremy Frommer was appointed as our Chief Executive Officer and Rick Schwartz was appointed as our President.

(2) Effective February 5, 2016,

Jeremy Frommer and Leonard Schiller were appointed as members of the Board of Directors.

(3) Effective May 2, 2016, Andrew

Taffin was appointed as a member of the Board of Directors.

(4) On January 31, 2019, Rick

Schwartz resigned from his position as President.

The Board of Directors appointed Justin Maury as President on

the same date.

Jeremy Frommer, Chief Executive Officer

Frommer, age 51, combines over 20 years

of experience in the financial technology industry.

Management’s report was not subject to attestation by our registered public accounting

firm pursuant to rules of the SEC that permit the Company to provide only management’s report herein.

Changes in Internal Control over Financial Reporting

were no changes in our internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange

Act, during our most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect,

our internal control over financial reporting.

Directors, Executive Officers and Corporate Governance.

and Executive Officers

The following table and biographical summaries set forth information,

including principal occupation and business experience, about our directors and executive officers as of the date of this Annual

Report on Form 10-K:

Executive Officer, Director

Chairman of the Board of Directors

Frommer –

Chief Executive Officer and Director

Frommer has served as our Chief Executive Officer and as

a member of our board of directors since February 2016.

Frommer has over 20 years of experience in the financial technology

Previously, Mr.

Frommer held key leaderships roles in the investment banking

and trading divisions of large financial institutions.

Frommer held key leaderships roles in the investment banking and trading divisions of large financial

institutions.

From 2009 to 2012, Mr.

Frommer was briefly retired until beginning concept

formation for Jerrick Ventures which he officially founded in 2013.

Frommer was briefly retired until beginning concept formation for Jerrick Ventures which he

officially founded in 2013.

From 2007 to 2009, Mr.

Frommer was Managing Director of Global

Prime Services at RBC Capital Markets, the investment banking arm of the Royal Bank of Canada, the largest financial institution

in Canada, after the sale of Carlin Financial Group, a professional trading firm.

Frommer was Managing Director of Global Prime Services at RBC Capital Markets,

the investment banking arm of the Royal Bank of Canada, the largest financial institution in Canada, after the sale of Carlin Financial

Group, a professional trading firm.

From 2004 to 2007, Mr.

Frommer was the Chief

Executive Officer of Carlin Financial Group after the sale of NextGen Trading, a software development company focused on building

equity trading platforms.

Frommer was the Chief Executive Officer of Carlin Financial Group after

the sale of NextGen Trading, a software development company focused on building equity trading platforms.

From 2002 to 2004, Mr.

Frommer was Founder and Chief Executive Officer of NextGen Trading.

to 2002, he was Managing Director of Merger Arbitrage Trading at Bank of America, a financial services firm.

Frommer was also

a director of LionEye Capital, a hedge fund from June 2012 to June 2014.

From 2000 to 2002, he was Managing Director of Merger Arbitrage

Trading at Bank of America, a financial services firm.

Frommer was also a director of LionEye Capital, a hedge fund from June

2012 to June 2014.

He holds a B.A.

from the University of Albany.

Justin Maury, President

Justin Maury, age 30, is a full stack design

director with an expertise in product development.

With over ten years of design and product management experience in the creative

industry, Maury’s passion for the creative arts and technology ultimately resulted in the vision for Vocal.

Since joining

Jerrick in 2013, Maury has overseen the development and launch of the company’s flagship product, Vocal, an innovative platform

that provides storytelling tools and engaged communities for creators and brands to get discovered while funding their creativity.

Under Maury’s supervision, Vocal has achieved growth to over 380,000 creators across 34 genre-specific communities in its

first two years since launch.

Leonard Schiller, Director

Leonard Schiller, age 74, is President

and Managing Partner of the Chicago law firm of Schiller Klein PC and has been associated with the firm since 1977.

also has served as the President of The Dearborn Group, a residential property management and real estate company with properties

located in the Midwest.

Schiller has also been involved in the ownership of residential properties and commercial properties

throughout the country.

Schiller has acted as a principal in numerous private loan transactions and has been responsible for

the structure, and management of these transactions.

Schiller has also served as a member of the Board of Directors of IMALL,

an internet search engine company, which was acquired by Excite@Home.

He also served as a member of the Board of AccuMed International,

Inc., a company which manufactured and marketed medical diagnostic screening products, which was acquired by Molecular Diagnostics,

He presently serves as a director of Milestone Scientific, Inc., a Delaware company and as a director of Point Capital, Inc.,

a Delaware corporation.

Andrew Taffin, Director

Andrew Taffin, age 52, has over 25 years

of entrepreneurial and executive leadership experience.

He is currently the Chief Executive Officer and co-founder of Tallen Technology

Rentals (“Tallen”), a leading provider of technology services and short-term rental AV equipment for businesses and

organizations of all sizes.

Taffin’s leadership, Tallen has experienced consistent revenue growth, secured multimillion

dollar contracts with Fortune 100 companies, expanded into multiple business categories including pharmaceutical and financial

services, and established a global presence to include supporting clients across the globe.

Taffin was also one of the founding

members and former president of the International Technology Rental Associations (“ITRA”).

Taffin is a consistent

speaker at industry conferences and events and contributes regularly to several technology publications.

Taffin graduated from

Plymouth State University with a B.A.

in communications.

The members of the Board of Directors serve

until the next annual meeting of stockholders, or until their successors have been elected.

When considering whether directors and

nominees have the experience, qualifications, attributes and skills to enable the Board of Directors to satisfy its oversight responsibilities

effectively in light of the Company’s business and structure, the Board of Directors focuses primarily on the industry and

transactional experience, and other background, in addition to any unique skills or attributes associated with a director.

regard to Mr.

Frommer, the Board of Directors considered his significant experience, expertise and background with regard

to the Company’s business and his prior experience as a chief executive for other business enterprises.

Schiller, the Board of Directors considered his background and experience as an investor in many different businesses,

together with his prior experience serving on the boards of public and private companies.

With regard to Mr.

Taffin, the Board

of Directors considered his management experience in growing small businesses.

Family Relationships

There are currently no family relationships

among any of our directors or executive officers.

Board Committees

Our Board of Directors does not have any

committees formed.

As independent directors are added to our board, we intend to form a formal Audit Committee, Compensation

Committee and Nominating and Corporate Governance Committee and adopt appropriate written charters for such committees.

however, there are no plans to appoint certain directors to specific committees.

Until such time as an Audit Committee,

Compensation Committee and Nominating and Corporate Governance Committee is formed, the full Board of Directors fulfills the functions

normally undertaken by such committees.

Compliance with Section 16(a) of the

Section 16(a)

of the Exchange Act requires the Company’s directors, executive officers and persons who beneficially own 10% or more of

a class of securities registered under Section 12 of the Exchange Act to file reports of beneficial ownership and changes in beneficial

ownership with the SEC.

Directors, executive officers and greater than 10% stockholders are required by the rules and regulations

of the SEC to furnish the Company with copies of all reports filed by them in compliance with Section 16(a).

Based solely on

our review of certain reports filed with the Securities and Exchange Commission pursuant to Section 16(a) of the Securities Exchange

Act of 1934, as amended, the reports required to be filed with respect to transactions in our common stock during the fiscal year

ended December 31, 2018, the following persons did not file timely.

Leonard Schiller, a member of our Board, did not file timely two

times, but has made all required filings as of this date;

Andrew Taffin, a member of our Board, did not file timely once,

but has made all required filings as of this date.

Arthur Rosen,

a beneficial owner of more than 10% of our Common Stock did not file his Form 3 on a timely basis during the fiscal year ended

December 31, 2017.

On April 23, 2018, Mr.

Rosen filed a Form 3 and a Schedule 13D.

To the Company’s knowledge, Mr.

has made all required filings as of this date.

Code of Ethics

The Company does not currently maintain

a Code of Ethics but plans to adopt one in the near future.

Legal Proceedings

There are no material proceedings to which

any director or officer, or any associate of any such director or officer, is a party that is adverse to our Company or any of

our subsidiaries or has a material interest adverse to our Company or any of our subsidiaries.

We believe Mr.

Frommer is qualified to serve on our board

of directors due to his financial and leadership experience.

Maury –

Maury has served as our President since January 2019.

is a full stack design director with an expertise in product development.

With over ten years of design and product management

experience in the creative industry, Mr.

Maury’s passion for the creative arts and technology ultimately resulted in the

vision for Vocal.

Since joining Jerrick in 2013, Maury has overseen the development and launch of the company’s flagship

product, Vocal, an innovative platform that provides storytelling tools and engaged communities for creators and brands to get

discovered while funding their creativity.

Under Maury’s supervision, Vocal has achieved growth to over 380,000 creators

across 34 genre-specific communities in its first two years since launch.

Leonard Schiller –

Chairman of the Board of Directors

Schiller is the Chairman of our board of directors.

President and Managing Partner of the Chicago law firm of Schiller, Strauss and Lavin PC and has been associated with the firm

Schiller also has served as the President of The Dearborn Group, a residential property management and real estate

company with properties located in the Midwest.

Schiller has also been involved in the ownership of residential properties

and commercial properties throughout the country.

Schiller has acted as a principal in numerous private loan transactions and

has been responsible for the structure, and management of these transactions.

Schiller has also served as a member of the Board

of Directors of IMALL, an internet search engine company, which was acquired by Excite@Home.

He also served as a member of the

Board of AccuMed International, Inc., a company which manufactured and marketed medical diagnostic screening products, which was

acquired by Molecular Diagnostics, Inc.

He presently serves as a director of Milestone Scientific, Inc., a Delaware company and

as a director of Point Capital, Inc., a Delaware corporation.

We believe Mr.

Schiller is qualified to serve on our board of

directors due to his legal and business experience.

Relationships

are currently no family relationships among any of our directors or executive officers.

Our board of directors does not have any committees formed.

As independent directors are added to our board, we intend to form a formal audit committee, compensation committee and nominating

and corporate governance committee and adopt appropriate written charters for such committees.

Presently, however, there

are no plans to appoint certain directors to specific committees.

Until such time as an audit committee, compensation

committee and nominating and corporate governance committee is formed, our full board of directors fulfills the functions normally

undertaken by such committees.

with Section 16(a) of the Exchange Act

16(a) of the Exchange Act requires the Company’s directors, executive officers and persons who beneficially own 10% or more

of a class of securities registered under Section 12 of the Exchange Act to file reports of beneficial ownership and changes in

beneficial ownership with the SEC.

Directors, executive officers and greater than 10% stockholders are required by the rules and

regulations of the SEC to furnish the Company with copies of all reports filed by them in compliance with Section 16(a).

solely on our review of certain reports filed with the Securities and Exchange Commission pursuant to Section 16(a) of the Securities

Exchange Act of 1934, as amended, the reports required to be filed with respect to transactions in our common stock during the

fiscal year ended December 31, 2018, the following persons did not file timely:

Andrew Taffin, a former member of our board of

directors, failed to file one report on Form 4.

Company does not currently maintain a Code of Ethics.

are no material proceedings to which any director or officer, or any associate of any such director or officer, is a party that

is adverse to our Company or any of our subsidiaries or has a material interest adverse to our Company or any of our subsidiaries.

No director or executive officer has been a director or executive officer of any business which has filed a bankruptcy petition

or had a bankruptcy petition filed against it during the past ten years.

No director or executive officer has been convicted of

a criminal offense or is the subject of a pending criminal proceeding during the past ten years.

No director or executive officer

has been a director or executive officer of any business which has filed a bankruptcy petition or had a bankruptcy petition filed

against it during the past ten years.

No director or executive officer has been convicted of a criminal offense or is the subject

of a pending criminal proceeding during the past ten years.

No director or executive officer has been the subject of any order,

judgment or decree of any court permanently or temporarily enjoining, barring, suspending or otherwise limiting his involvement

in any type of business, securities or banking activities during the past ten years.

No director or officer has been found by a

court to have violated a federal or state securities or commodities law during the past ten years.

has been the subject of any order, judgment or decree of any court permanently or temporarily enjoining, barring, suspending or

otherwise limiting his involvement in any type of business, securities or banking activities during the past ten years.

or officer has been found by a court to have violated a federal or state securities or commodities law during the past ten years.

Executive Compensation.

The following summary compensation table

sets forth all compensation awarded to, earned by, or paid to the named executive officers paid by us during the years ended December

31, 2018, and 2017.

and Principal

Compensation Table

following summary compensation table sets forth all compensation awarded to, earned by, or paid to the named executive officers

paid by us during the years ended December 31, 2019, and 2018.

Name and Principal

Incentive Plan

Chief Executive Officer

Jeremy Frommer

$ 104,667 (1)

Chief Executive Officer

Rick Schwartz

Former President

(1) The $132,792 includes payment to Mr.

Frommer for living

expenses, health insurance and a vehicle allowance.

$104,667 includes payment to Mr.

Frommer for living expenses, health insurance and a vehicle allowance.

$9,708 includes payment to Mr.

Schwartz for health insurance.

The $96,463 includes payment to Mr.

Schwartz for health

Frommer for living expenses, health insurance and a vehicle allowance.

The $8,094 includes payment to Mr.

Frommer for living

expenses, health insurance and a vehicle allowance.

Maury for health insurance.

Employment Agreements

As of April 1, 2019, the Company has not

entered into any employment agreements, but intends on entering into such agreements with its Chief Executive Officer and President

in the fiscal year 2019.

Outstanding Equity Awards at Fiscal

Year-End 2018

At December 31, 2018, we had outstanding

equity awards as follows:

Number of Securities Underlying Unexercised Options Exercisable

Number of Securities Underlying Unexercised Options Unexercisable

Equity Incentive Plan Awards:

Number of Securities Underlying Unexercised Unearned Options

As of March 30, 2020, the Company has not entered into any employment

agreements, but intends on entering into such agreements with its Chief Executive Officer and President by the end of fiscal year

Equity Awards at Fiscal Year-End 2018

December 31, 2019, we had outstanding equity awards as follows:

Unexercisable

Weighted Average

Exercise Price

Number of Shares or Units of Stock That Have Not Vested

Market Value of Shares or Units of Stock That Have Not Vested

Equity Incentive Plan Awards:

Number of Unearned Shares, Units or Other Rights That Have Not Vested

Equity Incentive Plan Awards:

Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested

Jeremy Frommer (1)

1 unchanged sentence

Justin Maury (2)

(1) Effective February 5, 2016, Jeremy Frommer was appointed

as our Chief Executive Officer and Rick Schwartz was appointed as our President.

(2) On January 31, 2019, Rick Schwartz resigned from his position

as President.

The Board of Directors appointed Justin Maury as President on the same date.

Security Ownership of Certain

Beneficial Owners and Management and Related Stockholder Matters.

As of the close of business April 1, 2019,

we had outstanding 134,256,350 shares of common stock.

Each share of common stock is currently entitled to one vote on all matters

put to a vote of our stockholders.

The following table sets forth the number of common shares, and percentage of outstanding common

shares, beneficially owned as of April 1, 2019, by:

person known by us to be the beneficial owner of more than five percent of our outstanding common stock;

of our current directors;

● each our current executive

officers and any other persons identified as a “named executive”

in the Summary Compensation Table above;

● all our current executive

officers and directors as a group.

Shares beneficially owned and percentage

ownership before this offering is based on 134,256,350 shares of common stock outstanding as of April 1, 2019.

Beneficial ownership is determined in accordance

with the rules of the SEC, and includes general voting power and/or investment power with respect to securities.

common stock issuable upon exercise of options or warrants that are currently exercisable or exercisable within 60 days of the

record date, and shares of common stock issuable upon conversion of other securities currently convertible or convertible within

60 days, are deemed outstanding for computing the beneficial ownership percentage of the person holding such securities but are

not deemed outstanding for computing the beneficial ownership percentage of any other person.

Under the applicable SEC rules, each

person’s beneficial ownership is calculated by dividing the total number of shares with respect to which they possess beneficial

ownership by the total number of outstanding shares.

In any case where an individual has beneficial ownership over securities

that are not outstanding, but are issuable upon the exercise of options or warrants or similar rights within the next 60 days,

that same number of shares is added to the denominator in the calculation described above.

Because the calculation of each person’s

beneficial ownership set forth in the “Percentage Beneficially Owned”

column of the table may include shares that are

not presently outstanding, the sum total of the percentages set forth in such column may exceed 100%.

Unless otherwise

indicated, the address of each of the following persons is 2050 Center Avenue, Suite 640, Fort Lee, NJ 07024, and, based upon information

available or furnished to us, each such person has sole voting and investment power with respect to the shares set forth opposite

his, her or its name.

Name and Address

February 5, 2016, Jeremy Frommer was appointed as our Chief Executive Officer and Rick Schwartz was appointed as our President.

January 31, 2019, Rick Schwartz resigned from his position as President.

The Board of Directors appointed Justin Maury

as President on the same date.

The following table presents the total compensation for each

person who served as a non-employee member of our board of directors and received compensation for such service during the fiscal

year ended December 31, 2019.

Other than as set forth in the table and described more fully below, we did not pay any compensation,

make any equity awards or non-equity awards to, or pay any other compensation to any of the non-employee members of our board of

directors in 2019.

Option Awards (1)

Andrew Taffin (2)

Leonard Schiller

shown in this column do not reflect dollar amounts actually received by our non-employee directors.

Instead, these amounts

represent the aggregate grant date fair value of stock option awards determined in accordance with FASB ASC Topic 718.

Taffin resigned from our board of directors on October 23, 2019.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

The following table sets forth certain information regarding

the Company’s common stock, beneficially owned as of March 30, 2020 (i) each person known to the Company to beneficially

own more than 5% of its common stock, (ii) each executive officer, director and director nominee and (iii) all officers, directors

and director nominees as a group.

The following table is based on the Company having 9,178,937 shares of common stock

issued and outstanding as of March 30, 2020.

The Company calculated beneficial ownership according to Rule 13d-3 of the Securities

Exchange Act of 1934, as amended as of that date.

Shares of the Company’s common stock issuable upon exercise

of options or warrants or conversion of notes that are exercisable or convertible within 60 days after March 30, 2020 are included

as beneficially owned by the holder, but not deemed outstanding for computing the percentage of any other stockholder for Percentage

of common stock Beneficially Owned.

For each individual and group included in the table below, percentage ownership is calculated

by dividing the number of shares beneficially owned by such person or group by the sum of the 9,178,937 shares of common stock

outstanding at March 30, 2020, plus the number of shares of common stock that such person or group had the right to acquire on

or within 60 days after March 30, 2020.

Beneficial ownership generally includes voting and dispositive power with respect to securities.

otherwise indicated below, the persons and entities named in the table have sole voting and sole dispositive power with respect

to all shares beneficially owned.

Beneficially Owned

5% or Greater Stockholders

Rick Schwartz

22,029,672 (2)

28,473,396 (3)

All 5% or Greater Stockholders as a Group

Named Executive Officers and Directors

Jeremy Frommer

16,124,726 (4)

3,907,517 (6)

Leonard Schiller

5,914,108 (7)

Andrew Taffin

3,353,343 (8)

All current directors and officers as a group

less than one percent

The securities “beneficially owned”

by a person are determined in accordance with the definition of “beneficial ownership”

set forth in the regulations of the SEC and accordingly, may include securities owned by or for, among others, the spouse, children or certain other relatives of such person, as well as other securities over which the person has or shares voting or investment power or securities which the person has the right to acquire within 60 days.

This total includes 10,877,672 shares of Common Stock and 11,152,045 shares underlying warrants.

This total includes 16,416, 896 shares of Common Stock and 12,056,500 shares underlying warrants.

This total includes 11,674,876 shares of Common Stock, 449,850 shares underlying warrants, and 4,000,000 shares underlying stock options.

This total includes 3,110,486 shares of Common Stock and 4,000,000 shares underlying stock options.

This total includes 548,427 shares of Common Stock and 3,359,090 shares underlying stock options.

This total includes 2,336,455 shares of Common Stock, 3,027,653 shares underlying warrants, and 600,000 shares underlying stock options.

This total includes 1,375,562 shares of Common Stock, 1,527,781 shares underlying warrants, and 500,000 shares underlying stock options.

Market for our Securities

Our Common Stock is quoted on the OTC Markets

OTCQB under the symbol “JMDA”.

The market price of our Common Stock is

subject to significant fluctuations in response to variations in our quarterly operating results, general trends in the market

and other factors, over many of which we have little or no control.

In addition, broad market fluctuations, as well as general

economic, business and political conditions, may adversely affect the market for our Common Stock, regardless of our actual or

projected performance.

Anti-Takeover Provisions

Our charter and bylaws contain provisions

that may make it more difficult for a third party to acquire or may discourage acquisition bids for us.

Our Board may, without

action of our stockholders, issue authorized but unissued shares of preferred stock.

The existence of unissued preferred stock

may enable the Board, without further action by the stockholders, to issue such stock to persons friendly to current management

or to issue such stock with terms that could render more difficult or discourage an attempt to obtain control of us, thereby protecting

the continuity of our management.

Our shares of preferred stock could therefore be issued quickly with terms that could delay,

defer, or prevent a change in control of us, or make removal of management more difficult.

Certain Relationships and Related

Transactions.

Upon completion of the Merger, as of February

5, 2016, the Company had a commercial lease agreement with 202 S Dean, LLC for its prior office building located at 202 S Dean

Street, Englewood, NJ 07631.

Under the agreement, the Company paid monthly rent to 202 S.

Dean LLC, which is 50% owned by our

Chief Executive Officer, Jeremy Frommer.

Monthly rent is $8,500 through 2015.

Commencing 2016 through the expiration of the lease,

monthly rent will be $14,165.

The lease expired April 30, 2018.

Before moving to the current office space, the Company paid rent

on a month-to-month basis at the rate of $14,165 per month.

On April 25, 2017, the Company issued

convertible notes to Arthur Rosen, a lender, totaling $25,000 (the “April Rosen Notes”).

The April Rosen Notes accrue

interest at 12% per annum and mature with interest and principal both due on September 1, 2017.

In addition, in connection with

the April Rosen Notes, the Company issued a five-year warrant to purchase 17,500 shares of Company common stock at a purchase

price of $0.20 per share.

On September 7, 2017, the April Rosen Notes and accrued interest was converted into the August 2017

Convertible Note Offering.

On April 25, 2017, the Company issued a

convertible note to Chris Gordon, a lender totaling $25,000 (the “April Gordon Notes”).

The April Gordon Notes accrue

interest at 12% per annum and matures with interest and principal both due on September 1, 2017.

In addition, the Company issued

a five-year warrant to purchase 17,500 shares of Company common stock at a purchase price of $0.20 per share.

The April Gordon

Notes and accrued interest were converted into the August 2017 Convertible Note Offering.

The August 2017 Convertible Note

Offering –

Related Party

During the year ended December 31, 2017,

the Company conducted multiple closings of a private placement offering to accredited investors (the “The August 2017 Convertible

Offering”) of units of the Company’s securities by entering into subscription agreements with “accredited investors”

(the “Investors”) for aggregate gross proceeds of $505,000.

In addition, $645,000 of the Company’s short term

debt along with accrued but unpaid interest of $206,026 was converted into the August 2017 Convertible Offering.

The conversions

resulted in the issuance of 4,555,129 warrants with a fair value of $440,157 and the increase of principal of $60,000.

These resulted

in a loss on extinguishment of debt of $500,157.

The Company offered, through a placement

agent, $6,000,000 of units of its securities (each, a “Unit”

and collectively, the “Units”), with each

Unit consisting of (a) a 15% Convertible Secured Promissory Note (each a “Note”

and together the “Notes”),

convertible into shares of the Company’s common stock, par value $.001 per share (“Conversion Shares”) at a conversion

price of $0.20 per share (the “Conversion Price”), and (b) a five-year warrant ( each a “Warrant and together

the “Warrants”) to purchase common stock equal to one hundred percent (100%) of the shares into which the Notes can

be converted into (“Warrant Shares”) at an exercise price of $0.20 per share (“Exercise Price”).

mature on the second (2nd) anniversary of their issuance dates.

The Conversion Price of the Note and the

Exercise Price of the Warrants are subject to adjustment for issuances of the Company’s common stock or any equity linked

instruments or securities convertible into the Company’s common stock at a purchase price of less than the prevailing Conversion

Price or Exercise Price.

Such adjustment shall result in the Conversion Price and Exercise Price being reduced to such lower purchase

price, subject to carve-outs as described therein.

The Company recorded a $160,700 debt discount

relating to 2,525,000 warrants issued to investors based on the relative fair value of each equity instrument on the dates of issuance.

The debt discount is being accreted over the life of the note to accretion of debt discount and issuance cost.

On December 21, 2017, the Company issued

a convertible note to a third party lender totaling $100,000 (the “Second December 2017 Note”).

The Second December

2017 Note accrues interest at 15% per annum and matures with interest and principal both due on December 27, 2019.

the Company issued a warrant to purchase 500,000 shares of Company common stock.

The warrant entitles the holder to purchase the

Company’s common stock at a purchase price of $0.20 per share for a period of five years from the issue date.

recorded a $36,722 debt discount relating to the warrants issued to the investor based on the relative fair value of each equity

instrument on the dates of issuance.

The debt discount is being accreted over the life of the note The Second December 2017 Note

and accrued interest is convertible at a conversion price of $0.20 per share, subject to adjustment.

The Second December 2017 Note

is secured as a second priority lien on the assets of the Company.

Notes payable

Notes payable –

related party as

of December 31, 2018 and 2017 is as follows:

Outstanding Principal as of

Maturity Date

The May 2016 Rosen Loan Agreement

November 26, 2017

The September 2017 Rosen Loan Agreement

September 24, 2017

The November 2017 Schiller Loan Agreement

December 31, 2017

The May 2018 Schiller Loan Agreements

February 2, 2019

The June 2018 Frommer Loan Agreement

August 17, 2018

The July 2018 Rosen Loan Agreement

August 17, 2018

The July 2018 Schiller Loan Agreements

August 17, 2018

The December 2018 Gravitas Loan Agreement

January 22, 2019

The December 2018 Rosen Loan Agreement

January 26, 2019

Debt Discount

On May 26, 2016, the Company entered into

a loan agreement (the “May 2016 Rosen Loan Agreement”) with Arthur Rosen, an individual (“Rosen”), pursuant

to which on May 26, 2016 (the “Closing Date”), Rosen provided the Company a secured term loan of $1,000,000 (the “May

2016 Rosen Loan”).

In connection with the May 2016 Rosen Loan Agreement, on May 26, 2016, the Company and Rosen entered into

a security agreement (the “Rosen Security Agreement”), pursuant to which the Company granted to Rosen a senior security

interest in substantially all of the Company’s assets as security for repayment of the May 2016 Rosen Loan.

Pursuant to the

May 2016 Rosen Loan Agreement, the May 2016 Rosen Loan bears interest at a rate of 12.5% per annum, compounded annually and payable

on the maturity date of May 26, 2017 (the “May 2016 Rosen Maturity Date”) at which time all outstanding principal,

5% or Greater Stockholders

1,503,203 (5)

than one percent

securities “beneficially owned”

by a person are determined in accordance with the definition of “beneficial

ownership”

set forth in the regulations of the SEC and accordingly, may include securities owned by or for, among others,

the spouse, children or certain other relatives of such person, as well as other securities over which the person has or shares

voting or investment power or securities which the person has the right to acquire within 60 days.

593,368 shares of common stock, 150 shares of common stock underlying warrants, and 200,000 shares of common stock underlying

stock options.

27,422 shares of common stock and 167,955 shares of common stock underlying stock options.

183,296 shares of common stock, 10,225 shares of common stock underlying warrants, and 30,000 shares of common stock underlying

stock options.

based on the Company’s review of filings made on a Schedule 13G on February 14, 2020 with the SEC.

Includes (i) 1,146,704

shares of Common Stock held directly by Mr.

Rosen, (ii) 132,074 shares of Common Stock held by Pearl Digital Opportunities

Fund LLC (“Pearl”), of which Mr.

Rosen is the Managing Member, (iii) warrants to acquire 10,000 shares of the

Company’s common stock, and (iv) warrants to acquire 20,000 shares of the Company’s common stock held Mr.

Rosen’s

minor children.

Certain Relationships and Related Transactions.

following includes a summary of transactions during our fiscal years ended December 31, 2019 and December 31, 2018 to which

we have been a party, including transactions in which the amount involved in the transaction exceeds the lesser of 

or 1% of the average of our total assets at year-end for the last two completed fiscal years, and in which any of our directors,

executive officers or, to our knowledge, beneficial owners of more than 5% of our capital stock or any member of the immediate

family of any of the foregoing persons had or will have a direct or indirect material interest, other than equity and other compensation,

termination, change in control and other arrangements, which are described elsewhere in this proxy statement.

We are not otherwise

a party to a current related party transaction, and no transaction is currently proposed, in which the amount of the transaction

exceeds the lesser of 

$120,000 or 1% of the average of our total assets at year-end for the last two completed fiscal years

and in which a related person had or will have a direct or indirect material interest.

January 2018 Rosen Loan Agreement

On January 16, 2018, the Company entered into a loan agreement

(the “January 2018 Rosen Loan Agreement”) with Arthur Rosen, a shareholder of the Company, whereby the Company issued

Rosen a promissory note in the principal amount of $60,000 (the “January 2018 Rosen Note”).

The January 2018 Rosen

Note is secured by Jeremy Frommer, our Chief Executive Officer, whereby upon default Mr.

Frommer’s personal shares of the

Company’s common stock would be available to Mr.

Rosen in an amount equal to the principal outstanding divided by 0.20.

to the January 2018 Rosen Loan Agreement, the January 2018 Rosen Note bears interest at a rate of 6% per annum and is payable on

the maturity date of January 31, 2018 (the “January 2018 Rosen Maturity Date”) at which time all outstanding principal,

accrued and unpaid interest and other amounts due under the May 2016 Rosen Loan are due.

The Company entered into an amendment

to the May 2016 Rosen Loan extending the May 2016 Rosen Maturity Date to November 26, 2017.

As additional consideration for entering

in the May 2016 Rosen Loan Agreement, the Company issued Rosen a five-year warrant to purchase 1,000,000 shares of the Company’s

common stock at a purchase price of $0.40 per share (the “May 2016 Rosen Warrant”).

The May 2016 Rosen Warrant contains

anti-dilution provisions as further described therein.

On September 7, 2017 (the “Conversion Date”), Rosen converted

all accrued but unpaid interest on the May 26 Rosen Loan from May 26, 2016 through September 6, 2017 in the amount of $124,306

(the “May 26 Rosen Loan Interest”) into the Company’s August Convertible Note Offering, after which May 26 Rosen

Loan Interest was deemed paid in full through the Conversion Date.

On September 12, 2016, the Company entered

into a loan agreement (the “September 2016 Rosen Loan Agreement”) with Rosen, pursuant to which on September 12, 2016

(the “Closing Date”), the Company issued Rosen a promissory note of $100,000 (the “September 2016 Rosen Note”).

Pursuant to the September 2016 Rosen Loan Agreement, the September 2016 Rosen Note bears interest at a rate of 12% per annum.

additional consideration for entering in the September 2016 Rosen Loan Agreement, the Company issued Rosen a five-year warrant

to purchase 150,000 shares of the Company’s common stock at a purchase price of $0.40 per share.

During the year ended December 31, 2018,

31, 2017 the principal and interest of this note were converted into the August 2017 Convertible Note Offering.

On October 13, 2016, the Company entered

into a loan agreement (the “October 2016 Gordon Loan Agreement”) with Chris Gordon, an individual (the “Gordon”),

pursuant to which on October 13, 2016 (the “Closing Date”), the Company issued a promissory note of $50,000 to Gordon

(the “October 2016 Gordon Note”).

Pursuant to the October 2016 Gordon Loan Agreement, the October 2016 Gordon Note

bears interest at a rate of 12% per annum.

As additional consideration for entering in the October 2016 Gordon Loan Agreement,

the Company issued Gordon a five-year warrant to purchase 50,000 shares of the Company’s common stock at a purchase price

of $0.40 per share.

During the year ended December 31, 2017 the principal and interest of this note were converted into the August

2017 Convertible Note Offering.

October 24, 2016, the Company entered into a loan agreement (the “October 2016 Schiller Loan Agreement”) with Leonard

Schiller, a Board Member (the “Schiller”), pursuant to which on October 24, 2016 (the “Closing Date”),

the Company issued Schiller a promissory note of $15,000 (the “October 2016 Schiller Note”).

Pursuant to the October

2016 Schiller Loan Agreement, the October 2016 Schiller Note bears interest at a rate of 9% per annum.

As additional consideration

for entering in the October 2016 Schiller Loan Agreement, the Company issued Schiller a 5-year warrant to purchase 30,000 shares

of the Company’s common stock at a purchase price of $0.30 per share.

During the year ended December 31, 2017 the principal

and interest of this note were converted into the August 2017 Convertible Note Offering.

October 31, 2016, the Company entered into a loan agreement (the “October 2016 Rosen Loan Agreement”) with Rosen,

pursuant to which on October 31, 2016 (the “Closing Date”), Company issued Rosen a promissory note of $10,000 (the

“October 2016 Rosen Note”).

Pursuant to the October 2016 Rosen Loan Agreement, the October 2016 Rosen Note bears interest

at a rate of 10% per annum.

As additional consideration for entering in the October 2016 Rosen Loan Agreement, the Company issued

Rosen a five-year warrant to purchase 10,000 shares of the Company’s common stock at a purchase price of $0.30 per share.

During the year ended December 31, 2017 the principal and interest of this note were converted into the August 2017 Convertible

Note Offering.

On December 21, 2016, the Company entered

into a loan agreement (the “December 2016 Gordon Loan Agreement”) with Gordon, pursuant to which on December 21, 2016

(the “Closing Date”), the Company issued Gordon a promissory note of $275,000 (the “December 2016 Gordon Note”).

Pursuant to the December 2016 Gordon Loan Agreement, the December 2016 Gordon Note bears interest at a rate of 10% per annum.

additional consideration for entering in the December 2016 Gordon Loan Agreement, the Company issued Gordon a five-year warrant

to purchase 166,666 shares of the Company’s common stock at a purchase price of $0.40 per share.

During the year ended December

31, 2017 the principal and interest of this note were converted into the August 2017 Convertible Note Offering.

On January 25, 2017, the Company entered

into a loan agreement (the “January 2017 Rosen Loan Agreement”) with Rosen pursuant to which on January 25, 2017 (the

“Closing Date”), the Company issued Rosen a promissory note of $50,000 (the “January 2017 Rosen Note”).

The January 2017 Rosen Note is secured by an officer of the Company.

Pursuant to the January 2017 Rosen Loan Agreement, the January

2017 Rosen Note bears interest at a rate of 10% per annum.

As additional consideration for entering in the January 2017 Rosen Loan

Agreement, the Company issued Rosen a five-year warrant to purchase 50,000 shares of the Company’s common stock at a purchase

price of $0.30 per share.

During the year ended December 31, 2017 the principal and interest of this note were converted into the

August 2017 Convertible Note Offering.

On January 26, 2017, the Company entered

into a loan agreement (the “January 2017 Gordon Loan Agreement”) with Gordon pursuant to which on January 26, 2017

(the “Closing Date”), the Company issued Gordon a promissory note of $50,000 (the “January 2017 Gordon Note”).

The January 2017 Gordon Note is secured by an officer of the Company.

Pursuant to the January 2017 Gordon Loan Agreement, the January

2017 Gordon Note bears interest at a rate of 10% per annum.

As additional consideration for entering in the January 2017 Gordon

Loan Agreement, the Company issued Gordon a five-year warrant to purchase 50,000 shares of the Company’s common stock at

a purchase price of $0.30 per share.

During the year ended December 31, 2017 the principal and interest of this note were repaid.

On February 7, 2017, the Company entered

into a loan agreement (the “February 2017 Schiller Loan Agreement”) with Schiller, a member of the Board, pursuant

to which on October 24, 2016 (the “Closing Date”), the Company issued Schiller a promissory note of $10,000 (the “February

2017 Schiller Note”).

The February 2017 Schiller Note is secured by an officer of the Company.

Pursuant to the February 2017

Schiller Loan Agreement, the February 2017 Schiller Note bears interest at a rate of 10% per annum.

As additional consideration

for entering in the February 2017 Schiller Note Loan Agreement, the Company issued Schiller a five-year warrant to purchase 10,000

shares of the Company’s common stock at a purchase price of $0.30 per share.

During the year ended December 31, 2017 the

principal and interest of this note were converted into the August 2017 Convertible Note Offering.

On April 12, 2017, the Company entered

into a loan agreement (the “April 2017 Schiller Loan Agreement”) with Schiller, a member of the Board, whereby the

Company issued Schiller a promissory note of $10,000 (the “April 2017 Schiller Note”).

The April 2017 Schiller Note

is secured by an officer of the Company.

Pursuant to the April 2017 Schiller Loan Agreement, the April 2017 Schiller Note bears

interest at a rate of 10% per annum.

As additional consideration for entering in the April 2017 Schiller Loan Agreement, the Company

issued Schiller a five-year warrant to purchase 10,000 shares of the Company’s common stock at a purchase price of $0.30

During the year ended December 31, 2017 the principal and interest of this note were converted into the August 2017

Convertible Note Offering.

On April 12, 2017, the Company entered

into a loan agreement (the “April 2017 Rosen Loan Agreement”) with Rosen, whereby the Company issued Rosen a promissory

note of $10,000 (the “April 2017 Rosen Note”).

The April 2017 Rosen Note is secured by an officer of the Company.

to the April 2017 Rosen Loan Agreement, the April 2017 Rosen Note bears interest at a rate of 10% per annum.

As additional consideration

for entering in the April 2017 Rosen Loan Agreement, the Company issued Rosen a five-year warrant to purchase 10,000 shares of

the Company’s common stock at a purchase price of $0.30 per share.

During the year ended December 31, 2017 the principal

and interest of this note were converted into the August 2017 Convertible Note Offering.

On May 4, 2017, the Company entered into

a loan agreement (the “May 2017 Rosen Loan Agreement”) with Rosen, whereby the Company issued Rosen a promissory note

of $15,000 (the “May 2017 Rosen Note”).

The May 2017 Rosen Note is secured by an officer of the Company.

the May 2017 Rosen Note Loan Agreement, the May 2017 Rosen Note bears interest at a rate of 12% per annum.

As additional consideration

for entering in the May 2017 Rosen Note Loan Agreement, the Company issued Rosen a five-year warrant to purchase 10,500 shares

of the Company’s common stock at a purchase price of $0.30 per share.

During the year ended December 31, 2017 the principal

and interest of this note were converted into the August 2017 Convertible Note Offering.

On May 11, 2017, the Company entered into

a loan agreement (the “May 2017 Schiller Loan Agreement”) with Schiller, a member of the Board, whereby the Company

issued Schiller a promissory note of $20,000 (the “May 2017 Schiller Note”).

Pursuant to the May 2017 Schiller Loan

Agreement, the May 2017 Schiller Note bears interest at a rate of 10% per annum.

As additional consideration for entering in the

May 2017 Schiller Note Loan Agreement, the Company issued Schiller a five-year warrant to purchase 20,000 shares of the Company’s

common stock at a purchase price of $0.20 per share.

During the year ended December 31, 2017 the principal and interest of this

note were converted into the August 2017 Convertible Note Offering.

On June 26, 2017, the Company entered into

a loan agreement (the “June 2017 Schiller Loan Agreement”) Schiller, a member of the Board, whereby the Company issued

Schiller a promissory note of $30,000 (the “June 2017 Schiller Note”).

Pursuant to the June 2017 Schiller Loan Agreement,

the June 2017 Schiller Note bears interest at a rate of 10% per annum.

As additional consideration for entering in the June 2017

Schiller Loan Agreement, the Company issued Schiller a five-year warrant to purchase 22,500 shares of the Company’s common

stock at a purchase price of $0.20 per share.

During the year ended December 31, 2017 the principal and interest of this note were

converted into the August 2017 Convertible Note Offering.

On July 6, 2017, the Company entered into

a loan agreement (the “July 2017 Rosen Loan Agreement”) with Rosen, whereby the Company issued Rosen a promissory note

of $25,000 (the “July 2017 Rosen Note”).

The July 2017 Rosen Note is secured by an officer of the Company.

to the July 2017 Rosen Note Loan Agreement, the July 2017 Rosen Note bears interest at a rate of 10% per annum.

As additional consideration

for entering in the July 2017 Rosen Note Loan Agreement, the Company issued Rosen a five-year warrant to purchase 18,750 shares

of the Company’s common stock at a purchase price of $0.20 per share.

During the year ended December 31, 2017 the principal

and interest of this note were converted into the August 2017 Convertible Note Offering.

On July 6, 2017, the Company entered into

a loan agreement (the “July 2017 Gordon Loan Agreement”) with Gordon, whereby the Company issued Gordon a promissory

note of $25,000 (the “July 2017 Gordon Note”).

The July 2017 Gordon Note is secured by an officer of the Company.

to the July 2017 Gordon Note Loan Agreement, the July 2017 Gordon Note bears interest at a rate of 10% per annum.

As additional

consideration for entering in the July 2017 Gordon Note Loan Agreement, the Company issued Gordon a five-year warrant to purchase

18,750 shares of the Company’s common stock at a purchase price of $0.20 per share.

During the year ended December 31, 2017

the principal and interest of this note were converted into the August 2017 Convertible Note Offering.

On August 24, 2017, the Company entered

into a loan agreement (the “August 2017 Rosen Loan Agreement”) with Rosen, whereby the Company issued Rosen a promissory

note of $20,000 (the “August 2017 Rosen Note”).

The August 2017 Rosen Note is secured by an officer of the Company.

Pursuant to the August 2017 Rosen Note Loan Agreement, the August 2017 Rosen Note bears interest at a rate of 12% per annum.

the year ended December 31, 2017 the principal and interest of this note were converted into the August 2017 Convertible Note Offering.

On September 8, 2017, the Company entered

into a loan agreement (the “September 2017 Rosen Loan Agreement”) with Rosen, whereby the Company issued Rosen a promissory

note of $224,000 (the “September 2017 Rosen Note”).

The September 2017 Rosen Note is secured by an officer of the Company.

As additional consideration for entering in the September 2017 Rosen Note Loan Agreement, the Company issued Rosen a five-year

warrant to purchase 1,650,000 shares of the Company’s common stock at a purchase price of $0.20 per share.

On November 20, 2017, the Company entered

into a loan agreement (the “November 2017 Schiller Loan Agreement”) Schiller, a member of the Board, whereby the Company

issued Schiller a promissory note of $25,000 (the “November 2017 Schiller Note”).

Pursuant to the November 2017 Schiller

Loan Agreement, the November 2017 Schiller Note bears interest at a rate of 15% per annum.

On November 20, 2017, the Company entered

into a loan agreement (the “November 2017 Rosen Agreement”) whereby the Company issued Rosen a promissory note of $25,000

(the “November 2017 Rosen Note”).

Pursuant to the November 2017 Rosen Loan Agreement, the November 2017 Rosen Note

bears interest at a rate of 15% per annum.

During the year ended December 31, 2017 the principal and interest of this note were

Line of credit

On May 9, 2017, the Company entered into

a Revolving Line of Credit (the “LOC”) with Grawin, LLC, an LLC controlled by Arthur Rosen, a related party.

is was established for a period of twelve months in which the Company can borrow principal up to $130,000.

The LOC bears interest

at a rate of 18%.

On May 09, 2017, in connection with the

LOC the Company issued a promissory note in the principal aggregate amount of $56,000 in favor Grawin, LLC.

On May 16, 2017, in connection with the

LOC the Company issued a promissory note in the principal aggregate amount of $30,000 in favor Grawin, LLC.

On May 22, 2017, in connection with the

LOC the Company issued a promissory note in the principal aggregate amount of $6,000 in favor Grawin, LLC.

On May 25, 2017, in connection with the

LOC the Company issued a promissory note in the principal aggregate amount of $35,000 in favor Grawin, LLC.

On June 16, 2017, in connection with the

LOC the Company issued a promissory note in the principal aggregate amount of $3,000 in favor Grawin, LLC.

The January 2018 Rosen Loan Agreement

On January 16, 2018, the Company entered

into a loan agreement (the “January 2018 Rosen Loan Agreement”) with Rosen, whereby the Company issued Rosen a promissory

note in the principal amount of $60,000 (the “January 2018 Rosen Note”).

The January 2018 Rosen Note is secured by

Jeremy Frommer, whereas upon default Mr.

Frommer would owe his own personal default shares of the Company’s common stock

to Rosen equal to the amount of principal outstanding divided by 0.20.

Pursuant to the January 2018 Rosen Loan Agreement, the January

2018 Rosen Note bears interest at a rate of 6% per annum and is payable on the maturity date of January 31, 2018 (the “January

2018 Rosen Maturity Date”) at which time all outstanding principal, accrued and unpaid interest and other amounts due under

the May 2016 Rosen Loan are due.

During the year ended December 31, 2018, the Company repaid $60,000 in principal and $200 in interest

and the loan is no longer outstandinng.

The January 2018 Gordon Loan Agreement

On January 16, 2018, the Company entered

into a loan agreement (the “January 2018 Gordon Loan Agreement”) with Mr.

Christopher Gordon (“Gordon”),

whereby the Company issued Gordon a promissory note in the principal amount of $40,000 (the “January 2018 Gordon Note”).

The January 2018 Gordon Note is secured by Jeremy Frommer, whereas upon default Mr.

Frommer would owe his own personal default

shares of the Company’s common stock to Gordon equal to the amount of principal outstanding divided by 0.20.

to the January 2018 Gordon Loan Agreement, the January 2018 Gordon Note bears interest at a rate of 6% per annum and payable on

the maturity date of January 31, 2018 (the “January 2018 Gordon Maturity Date”) at which time all outstanding principal,

the Company repaid $60,000 in principal and $200 in interest and the loan is no longer outstanding.

January 2018 Gordon Loan Agreement

On January 16, 2018, the Company entered into a loan agreement

(the “January 2018 Gordon Loan Agreement”) with Christopher Gordon (“Gordon”), whereby the Company issued

Gordon a promissory note in the principal amount of $40,000 (the “January 2018 Gordon Note”).

The January 2018

Gordon Note is secured by Jeremy Frommer, our Chief Executive Officer, whereby upon default Mr.

Frommer’s personal shares

of the Company’s common stock would be available to Mr.

Gordon in amount equal to the principal outstanding divided by 0.20.

Pursuant to the January 2018 Gordon Loan Agreement, the January 2018 Gordon Note bears interest at a rate of 6% per annum and payable

on the maturity date of January 31, 2018 (the “January 2018 Gordon Maturity Date”) at which time all outstanding principal,

accrued and unpaid interest and other amounts due under the January 2018 Gordon Note are due.

1 unchanged sentence

2018, the Company repaid $40,000 in principal and $105 in interest and the loan is no longer outstanding.

The First March 2018 Rosen Loan Agreement

On March 4, 2018, the Company entered into

a loan agreement (the “First March 2018 Rosen Loan Agreement”) with Rosen, whereby the Company issued Rosen a promissory

note in the principal amount of $10,000 (the “First March 2018 Rosen Note”).

As additional consideration for entering

in the First March 2018 Rosen Note Loan Agreement, the Company issued Rosen a five-year warrant to purchase 10,000 shares of the

First March 2018 Rosen Loan Agreement

On March 4, 2018, the Company entered into a loan agreement

(the “First March 2018 Rosen Loan Agreement”) with Mr.

Rosen, whereby the Company issued Mr.

Rosen a promissory note

in the principal amount of $10,000 (the “First March 2018 Rosen Note”).

As additional consideration for entering in

the First March 2018 Rosen Note Loan Agreement, the Company issued Mr.

Rosen a five-year warrant to purchase 10,000 shares of the

Company’s common stock at a purchase price of $0.20 per share.

5 unchanged sentences

in principal and $260 in interest and the loan is no longer outstanding.

The Second March 2018 Rosen Loan

On March 9, 2018, the Company entered into

a loan agreement (the “Second March 2018 Rosen Loan Agreement”) with Rosen, whereby the Company issued Rosen a promissory

note in the principal amount of $15,000 (the “Second March 2018 Rosen Note”).

As additional consideration for entering

in the Second March 2018 Rosen Loan Agreement, the Company issued Rosen a five-year warrant to purchase 15,000 shares of the Company’s

Second March 2018 Rosen Loan Agreement

On March 9, 2018, the Company entered into a loan agreement

(the “Second March 2018 Rosen Loan Agreement”) with Mr.

Rosen, whereby the Company issued Mr.

Rosen a promissory note

in the principal amount of $15,000 (the “Second March 2018 Rosen Note”).

As additional consideration for entering in

the Second March 2018 Rosen Loan Agreement, the Company issued Mr.

Rosen a five-year warrant to purchase 15,000 shares of the Company’s

common stock at a purchase price of $0.20 per share.

5 unchanged sentences

and $365 in interest and the loan is no longer outstanding.

The Third March 2018 Rosen Loan Agreement

On March 13, 2018, the Company entered

into a loan agreement (the “Third March 2018 Rosen Loan Agreement”) with Rosen, whereby the Company issued Rosen a

promissory note in the principal amount of $10,000 (the “Third March 2018 Rosen Note”).

As additional consideration

for entering in the Third March 2018 Rosen Loan Agreement, the Company issued Rosen a five-year warrant to purchase 10,000 shares

of the Company’s common stock at a purchase price of $0.20 per share.

Pursuant to the Third March 2018 Rosen Loan Agreement,

the Third March 2018 Rosen Note bears interest at a rate of 12% per annum and is payable on the maturity date of March 28, 2018

(the “Third March 2018 Rosen Maturity Date”) at which time all outstanding principal, accrued and unpaid interest and

other amounts due under the Third March 2018 Rosen Note was due.

During the nine months ended December 31, 2018, the Company repaid

$10,000 in principal and $230 in interest and the loan is no longer outstanding.

The May 2018 Schiller Loan Agreement

On May 2, 2018, the Company entered into

a loan agreement (the “May 2018 Schiller Loan Agreement”) with Schiller, a member of the Board, whereby the Company

issued Schiller a promissory note in the principal amount of $100,000 (the “May 2018 Schiller Note”).

Third March 2018 Rosen Loan Agreement

On March 13, 2018, the Company entered into a loan agreement

(the “Third March 2018 Rosen Loan Agreement”) with Mr.

Rosen, whereby the Company issued Mr.

Rosen a promissory note

in the principal amount of $10,000 (the “Third March 2018 Rosen Note”).

As additional consideration for entering in

the Third March 2018 Rosen Loan Agreement, the Company issued Mr.

Rosen a five-year warrant to purchase 10,000 shares of the Company’s

common stock at a purchase price of $0.20 per share.

Pursuant to the Third March 2018 Rosen Loan Agreement, the Third March 2018

Rosen Note bears interest at a rate of 12% per annum and is payable on the maturity date of March 28, 2018 (the “Third March

2018 Rosen Maturity Date”) at which time all outstanding principal, accrued and unpaid interest and other amounts due under

the Third March 2018 Rosen Note was due.

During the nine months ended December 31, 2018, the Company repaid $10,000 in principal

and $230 in interest and the loan is no longer outstanding.

May 2018 Schiller Loan Agreement

On May 2, 2018, the Company entered into a loan agreement (the

“May 2018 Schiller Loan Agreement”) with Leonard Schiller, Chairman of our board of directors, whereby the Company

Schiller a promissory note in the principal amount of $100,000 (the “May 2018 Schiller Note”).

As additional

consideration for entering in the May 2018 Schiller Loan Agreement, the Company issued Schiller a four-year warrant to purchase

consideration for entering in the May 2018 Schiller Loan Agreement, the Company issued Mr.

Schiller a four-year warrant to purchase

300,000 shares of the Company’s common stock at a purchase price of $0.20 per share.

3 unchanged sentences

are due under the May 2018 Schiller Loan.

During the year ended December 31, 2018,

the Company converted $100,000 of principal and $4,369 of unpaid interest into the August 2018 Equity Raise (as defined below)

and the loan is no longer outstanding.

The June 2018 Frommer Loan Agreement

On June 29, 2018, the Company entered into

a loan agreement (the “June 2018 Frommer Loan Agreement”) with Jeremy Frommer, an officer of the Company, whereby the

Company issued Frommer a promissory note in the principal amount of $10,000 (the “June 2018 Frommer Note”).

As additional

consideration for entering in the June 2018 Frommer Note Loan Agreement, the Company issued Frommer a four-year warrant to purchase

30,000 shares of the Company’s common stock at a purchase price of $0.20 per share.

Pursuant to the June 2018 Frommer Loan

Agreement, the June 2018 Frommer Note bears interest at a rate of 6% per annum and payable on the maturity date of August 17, 2018

(the “June 2018 Frommer Maturity Date”) at which time all outstanding principal, accrued and unpaid interest are due

under the June 2018 Frommer Loan.

Subsequent to the balance sheet date, on November 8, 2018 the Company executed upon an

agreement that extended the maturity date of this loan to March 7, 2019.

As part of the extension agreement, the Company issued

40,854 warrants to purchase common stock of the Company at an exercise price of $0.30.

On March 29, 2019 the Company executed upon

an agreement that extended the maturity date of this loan to May 15, 2019.

The First July 2018 Schiller Loan

On July 3, 2018, the Company entered into

a loan agreement (the “First July 2018 Schiller Loan Agreement”) with Schiller, a member of the Board, whereby the

Company issued Schiller a promissory note of $35,000 (the “First July 2018 Schiller Note”).

As additional consideration

for entering in the First July 2018 Schiller Loan Agreement, the Company issued Schiller a four-year warrant to purchase 75,000

shares of the Company’s common stock at a purchase price of $0.20 per share.

Pursuant to the agreement, the note bears interest

at a rate of 6% per annum and payable on the maturity date of August 17, 2018 at which time all outstanding principal, accrued

and unpaid interest were due under the First July 2018 Schiller Loan.

Subsequent to the balance sheet date, on November 8,

2018 the Company executed upon an agreement that extended the maturity date of this loan to March 7, 2019.

As part of the extension

agreement, the Company issued 142,987 warrants to purchase common stock of the Company at an exercise price of $0.30.

29, 2019 the Company executed upon an agreement that extended the maturity date of this loan to May 15, 2019.

The Second July 2018 Schiller Loan

On July 17, 2018, the Company entered into

a loan agreement (the “Second July 2018 Schiller Loan Agreement”) with Schiller, a member of the Board, whereby the

Company issued Schiller a promissory note of $25,000 (the “Second July 2018 Schiller Note”).

the year ended December 31, 2018, the Company converted $100,000 of principal and $4,369 of unpaid interest into the August 2018

Equity Raise (as defined below) and the loan is no longer outstanding.

June 2018 Frommer Loan Agreement

On June 29, 2018, the Company entered into a loan agreement

(the “June 2018 Frommer Loan Agreement”) with Jeremy Frommer our Chief Executive Officer, whereby the Company issued

Frommer a promissory note in the principal amount of $10,000 (the “June 2018 Frommer Note”).

As additional consideration

for entering in the Second July 2018 Schiller Loan Agreement, the Company issued Schiller a four-year warrant to purchase 75,000

shares of the Company’s common stock at a purchase price of $0.20 per share.

Pursuant to the Second July 2018 Schiller Loan

Agreement, the Second July 2018 Schiller Note bears interest at a rate of 6% per annum and payable on the maturity date of August

for entering in the June 2018 Frommer Note Loan Agreement, the Company issued Frommer a four-year warrant to purchase 30,000 shares

of the Company’s common stock at a purchase price of $0.20 per share.

Pursuant to the June 2018 Frommer Loan Agreement, the

June 2018 Frommer Note bears interest at a rate of 6% per annum and payable on the maturity date of August 17, 2018 (the “June

2018 Frommer Maturity Date”) at which time all outstanding principal, accrued and unpaid interest are due under the June

2018 Frommer Loan.

Subsequent to the balance sheet date, on November 8, 2018 the Company executed upon an agreement that

extended the maturity date of this loan to March 7, 2019.

As part of the extension agreement, the Company issued 40,854 warrants

to purchase common stock of the Company at an exercise price of $0.30.

On March 29, 2019 the Company executed upon an agreement

that extended the maturity date of this loan to May 15, 2019.

On December 15, 2019 the Company executed upon an agreement that further extended the maturity date of

this loan to May 15, 2020.

First July 2018 Schiller Loan Agreement

On July 3, 2018, the Company entered into a loan agreement (the

“First July 2018 Schiller Loan Agreement”) with Leonard Schiller, a member of the Board, whereby the Company issued

Schiller a promissory note of $35,000 (the “First July 2018 Schiller Note”).

As additional consideration for entering

in the First July 2018 Schiller Loan Agreement, the Company issued Schiller a four-year warrant to purchase 75,000 shares of the

Company’s common stock at a purchase price of $0.20 per share.

Pursuant to the agreement, the note bears interest at a rate

of 6% per annum and payable on the maturity date of August 17, 2018 at which time all outstanding principal, accrued and unpaid

interest were due under the First July 2018 Schiller Loan.

Subsequent to the balance sheet date, on November 8, 2018 the

Company executed upon an agreement that extended the maturity date of this loan to March 7, 2019.

As part of the extension agreement,

the Company issued 142,987 warrants to purchase common stock of the Company at an exercise price of $0.30.

On March 29, 2019 the

Company executed upon an agreement that extended the maturity date of this loan to May 15, 2019.

During the year ended December 31, 2018 the Company repaid $20,000

in principal.

During the year ended December 31, 2019, the Company converted $15,000 in principal and $863.33 into the February

2019 Offering and the note is no longer outstanding.

Second July 2018 Schiller Loan Agreement

On July 17, 2018, the Company entered into a loan agreement

(the “Second July 2018 Schiller Loan Agreement”) with Schiller, a member of the Board, whereby the Company issued Mr.

Schiller a promissory note of $25,000 (the “Second July 2018 Schiller Note”).

As additional consideration for entering

in the Second July 2018 Schiller Loan Agreement, the Company issued Mr.

Schiller a four-year warrant to purchase 75,000 shares

of the Company’s common stock at a purchase price of $0.20 per share.

Pursuant to the Second July 2018 Schiller Loan Agreement,

the Second July 2018 Schiller Note bears interest at a rate of 6% per annum and payable on the maturity date of August 17, 2018

at which time all outstanding principal, accrued and unpaid interest were due under the Second July 2018 Schiller Loan.

Subsequent to the balance sheet date, on November 8, 2018 the Company executed upon an agreement that extended the maturity date

of this loan to March 7, 2019.

As part of the extension agreement, the Company issued 101,900 warrants to purchase common stock

of the Company at an exercise price of $0.30.

On March 29, 2019 the Company executed upon an agreement that extended the maturity

date of this loan to May 15, 2019.

The First July 2018 Rosen Loan Agreements

On July 12, 2018, the Company entered into

a loan agreement (the “First July 2018 Rosen Loan Agreement”) with Rosen, an officer of the Company, whereby the Company

issued Rosen a promissory note of $10,000 (the “First July 2018 Rosen Note”).

Pursuant to the First July 2018 Rosen

Loan Agreement, the note bears interest at a rate of 6% per annum and payable on the maturity date of August 17, 2018 at which

time all outstanding principal, accrued and unpaid interest are due under the First July 2018 Rosen Note.

to the balance sheet date, on November 8, 2018 the Company entered into an agreement with Mr.

Schiller that extended the maturity

date of this loan to March 7, 2019.

As part of the extension agreement, the Company issued 101,900 warrants to Mr.

purchase common stock of the Company at an exercise price of $0.30.

On March 29, 2019 the Company entered into an agreement that

extended the maturity date of this loan to May 15, 2019.

On December 15, 2019 the Company executed upon an agreement that further extended the maturity date of

this loan to May 15, 2020.

During the year ended December 31, 2019 the Company converted

$4,136.67 in principal into the February 2019 Offering.

First July 2018 Rosen Loan Agreements

On July 12, 2018, the Company entered into a loan agreement

(the “First July 2018 Rosen Loan Agreement”) with Mr.

Rosen, a shareholder of the Company, whereby the Company issued

Rosen a promissory note of $10,000 (the “First July 2018 Rosen Note”).

Pursuant to the First July 2018 Rosen Loan

Agreement, the note bears interest at a rate of 6% per annum and payable on the maturity date of August 17, 2018 at which time

all outstanding principal, accrued and unpaid interest are due under the First July 2018 Rosen Note.

Subsequent to the balance

sheet date, on November 8, 2018 the Company executed upon an agreement that extended the maturity date of this loan to March 7,

As part of the extension agreement, the Company issued 27,534 warrants to purchase common stock of the Company at an exercise

price of $0.30.

On March 29, 2019 the Company executed upon an agreement that extended the maturity date of this loan to May 15,

The Second July 2018 Rosen Loan Agreements

On July 18, 2018, the Company entered into

a loan agreement (the “Second July 2018 Rosen Loan Agreement”) with Rosen, whereby the Company issued Rosen a promissory

note of $50,000 (the “Second July 2018 Rosen Note”) resulting from the conversion of a demand note (as described below).

As additional consideration for entering into the Second July 2018 Rosen Loan Agreement, the Company issued Rosen a four-year warrant

to purchase 150,000 shares of the Company’s common stock at a purchase price of $0.20 per share.

Pursuant to the Second July

2018 Rosen Loan Agreement, the Second July 2018 Rosen Note bears interest at a rate of 6% per annum and payable on the maturity

date of August 17, 2018 at which time all outstanding principal, accrued and unpaid interest are due under the Second July 2018

Subsequent to the balance sheet date, on November 8, 2018 the Company executed upon an agreement that extended the

maturity date of this loan to March 7, 2019.

As part of the extension agreement, the Company issued 203,967 warrants to purchase

common stock of the Company at an exercise price of $0.30.

On March 29, 2019 the Company executed upon an agreement that extended

the maturity date of this loan to May 15, 2019.

The November 2018 Rosen Loan Agreement

On November 29, 2018, the Company entered

into a loan agreement (the “November 2018 Rosen Loan Agreement”) with Rosen, whereby the Company issued Rosen a promissory

note in the principal amount of $25,000 (the “November 2018 Rosen Note”).

As additional consideration for entering

in the November 2018 Rosen Note Loan Agreement, the Company issued Rosen a four-year warrant to purchase 25,000 shares of the Company’s

As part of the extension agreement, the Company issued to Mr.

Rosen 27,534 warrants to purchase common stock of the Company

at an exercise price of $0.30.

On March 29, 2019 the Company entered into an agreement that extended the maturity date of this

loan to May 15, 2019.

During the year ended December 31, 2019, the Company repaid

$10,000 of principal and all unpaid interest and the loan is no longer outstanding.

Second July 2018 Rosen Loan Agreements

On July 18, 2018, the Company entered into a loan agreement

(the “Second July 2018 Rosen Loan Agreement”) with Rosen, whereby the Company issued Mr.

Rosen a promissory note of

$50,000 (the “Second July 2018 Rosen Note”) resulting from the conversion of a demand note (as described below).

additional consideration for entering into the Second July 2018 Rosen Loan Agreement, the Company issued Mr.

Rosen a four-year

warrant to purchase 150,000 shares of the Company’s common stock at a purchase price of $0.20 per share.

Pursuant to the

Second July 2018 Rosen Loan Agreement, the Second July 2018 Rosen Note bears interest at a rate of 6% per annum and payable on

the maturity date of August 17, 2018 at which time all outstanding principal, accrued and unpaid interest are due under the Second

July 2018 Rosen Note.

Subsequent to the balance sheet date, on November 8, 2018 the Company entered into an agreement that extended

the maturity date of this loan to March 7, 2019.

As part of the extension agreement, the Company issued to Mr.

Rosen 203,967 warrants

to purchase common stock of the Company at an exercise price of $0.30.

On March 29, 2019 the Company entered into an agreement

that extended the maturity date of this loan to May 15, 2019.

During the year ended December 31, 2019, the Company repaid

$50,000 of principal and all unpaid interest and the loan is no longer outstanding.

November 2018 Rosen Loan Agreement

On November 29, 2018, the Company entered into a loan agreement

(the “November 2018 Rosen Loan Agreement”) with Mr.

Rosen, whereby the Company issued Mr.

Rosen a promissory note in

the principal amount of $25,000 (the “November 2018 Rosen Note”).

As additional consideration for entering in the November

2018 Rosen Note Loan Agreement, the Company issued Mr.

Rosen a four-year warrant to purchase 25,000 shares of the Company’s

common stock at a purchase price of $0.30 per share.

2 unchanged sentences

Maturity Date”) at which time all outstanding principal, accrued and unpaid interest are due under the November 2018 Rosen

During the year ended December 31, 2018,

the Company repaid $25,000 of principal and $33 of unpaid interest and the loan is no longer outstanding.

The December 2018 Rosen Loan Agreement

On December 27, 2018, the Company entered

into a loan agreement (the “December 2018 Rosen Loan Agreement”) with Rosen, whereby the Company issued Rosen a promissory

note in the principal amount of $75,000 (the “December 2018 Rosen Note”).

As additional consideration for entering

in the December 2018 Rosen Note Loan Agreement, the Company issued Rosen a four-year warrant to purchase 75,000 shares of the Company’s

the year ended December 31, 2018, the Company repaid $25,000 of principal and $33 of unpaid interest and the loan is no longer

December 2018 Rosen Loan Agreement

On December 27, 2018, the Company entered into a loan agreement

(the “December 2018 Rosen Loan Agreement”) with Mr.

Rosen, whereby the Company issued Mr.

Rosen a promissory note in

the principal amount of $75,000 (the “December 2018 Rosen Note”).

As additional consideration for entering in the December

2018 Rosen Note Loan Agreement, the Company issued Mr.

Rosen a four-year warrant to purchase 75,000 shares of the Company’s

common stock at a purchase price of $0.30 per share.

2 unchanged sentences

Maturity Date”) at which time all outstanding principal, accrued and unpaid interest are due under the November 2018 Rosen

On March 29, 2019 the Company executed upon an agreement that extended the maturity date of this loan to May 15, 2019.

The December 2018 Gravitas Capital

Loan Agreement

On December 27, 2018, the Company entered

into a loan agreement (the “December 2018 Gravitas Capital Loan Agreement”) with Gravitas Capital, whereby the Company

issued Gravitas Capital a promissory note in the principal amount of $50,000 (the “December 2018 Gravitas Capital Note”).

As additional consideration for entering in the December 2018 Gravitas Capital Note Loan Agreement, the Company issued Gravitas

Capital a four-year warrant to purchase 50,000 shares of the Company’s common stock at a purchase price of $0.30 per share.

Pursuant to the December 2018 Gravitas Capital Loan Agreement, the December 2018 Gravitas Capital Note bears interest at a rate

of 6% per annum and payable on the maturity date of January 27, 2018 (the “December 2018 Gravitas Capital Maturity Date”)

at which time all outstanding principal, accrued and unpaid interest are due under the November 2018 Gravitas Capital Loan.

January 2019, the Company repaid $50,000 in principal and $250 in interest, and the loan is no longer outstanding.

Director Independence

Our Board of Directors will periodically

review relationships that directors have with the Company to determine whether the directors are independent.

are considered “independent”

as long as they do not accept any consulting, advisory or other compensatory fee (other

than director fees) from the Company, are not an affiliated person of the Company or its subsidiaries (e.g., an officer or a greater-than-ten-percent

stockholder) and are independent within the meaning of applicable laws, regulations and the Nasdaq listing rules.

In this latter

regard, the Board of Directors will use the Nasdaq listing rules (specifically, Section 5605(a)(2) of such rules)

as a benchmark for determining which, if any, of its directors are independent, solely in order to comply with applicable SEC disclosure

However, this is for disclosure purposes only.

It should be understood that, as a corporation whose shares are not listed

for trading on any securities exchange, our Company is not required to have any independent directors at all on its Board of Directors,

or any independent directors serving on any particular committees of the Board of Directors.

As of the date of this Form 10-K, the Board

of Directors has determined that Leonard Schiller and Andrew Taffin are independent within the meaning of the Nasdaq listing rule cited

Principal Accountant Fees and

The following table sets forth the aggregate

fees billed for each of the last two fiscal years for professional services rendered by the principal accountant for the audit

of the Company’s annual financial statements and review of financial statements included in the Company’s quarterly

reports or services that are normally provided by the accountant in connection with statutory and regulatory filings or engagements

for those fiscal years.

Audit-Related

On March 29, 2019 the Company entered into an agreement that extended the maturity date of this loan to May 15, 2019.

During the year ended December 31, 2019, the Company converted

this loan and all unpaid interest into the June 2019 Loan Agreement and the loan is no longer outstanding.

December 2018 Gravitas Capital Loan Agreement

December 27, 2018, the Company entered into a loan agreement (the “December 2018 Gravitas Capital Loan Agreement”)

with Gravitas Capital, whereby the Company issued Gravitas Capital a promissory note in the principal amount of $50,000 (the “December

2018 Gravitas Capital Note”).

As additional consideration for entering in the December 2018 Gravitas Capital Note Loan Agreement,

the Company issued Gravitas Capital a four-year warrant to purchase 50,000 shares of the Company’s common stock at a purchase

price of $0.30 per share.

Pursuant to the December 2018 Gravitas Capital Loan Agreement, the December 2018 Gravitas Capital Note

bears interest at a rate of 6% per annum and payable on the maturity date of January 27, 2018 (the “December 2018 Gravitas

Capital Maturity Date”) at which time all outstanding principal, accrued and unpaid interest are due under the November

2018 Gravitas Capital Loan.

In January 2019, the Company repaid $50,000 in principal and $250 in interest, and the loan is no

longer outstanding.

January 2019 Rosen Loan Agreement

On January 30, 2019, the Company entered into a loan agreement

(the “January 2019 Rosen Loan Agreement”) with Mr.

Rosen, whereby the Company issued Mr.

Rosen a promissory note in

the principal amount of $175,000 (the “January 2019 Rosen Note”).

As additional consideration for entering in the January

2019 Rosen Note Loan Agreement, the Company issued Mr.

Rosen a four-year warrant to purchase 15,000 shares of the Company’s

common stock at a purchase price of $6.00 per share.

Pursuant to the January 2019 Rosen Loan Agreement, the January 2019 Rosen

Note bears interest at a rate of 10% per annum and payable on the maturity date of February 15, 2019 (the “January 2019 Rosen

Maturity Date”).

On February 19, 2018 the Company executed upon an agreement that extended the maturity date of this loan

to March 7, 2019.

As part of the extension agreement, the Company issued Mr.

Rosen warrants to purchase 35,194 shares of common

stock of the Company at an exercise price of $6.00.

On March 29, 2019 the Company entered into an agreement with Mr.

extended the maturity date of this loan to May 15, 2019.

August 8, 2019 the Company entered into an agreement further extending the maturity date to September 20, 2019.

the year ended December 31, 2019 the Company repaid $175,000 in principal and $15,073 in interest and the loan is no longer outstanding.

February 2019 Rosen Loan Agreement

On February 14, 2019, the Company entered into a loan agreement

(the “February 2019 Rosen Loan Agreement”) with Mr.

Rosen, whereby the Company issued Mr.

Rosen a promissory note in

the principal amount of $50,000 (the “February 2019 Rosen Note”).

As additional consideration for entering in the February

2019 Rosen Note Loan Agreement, the Company issued Mr.

Rosen a four-year warrant to purchase 5,000 shares of the Company’s

common stock at a purchase price of $6.00 per share.

Pursuant to the February 2019 Rosen Loan Agreement, the February 2019 Rosen

Note bears interest at a rate of 10% per annum and payable on the maturity date of February 28, 2019 (the “February 2019

Rosen Maturity Date”).

On March 29, 2019 the Company entered into an agreement with Mr.

Rosen that extended the maturity

date of this loan to May 15, 2019.

On August 8, 2019 the Company entered into an agreement further extending the maturity

date to September 20, 2019.

the year ended December 31, 2019 the Company repaid $50,000 in principal and $3,208 in interest and the loan is no longer outstanding.

June 2019 Loan Agreement

On June 3, 2019, the Company entered into a loan agreement (the

“June 2019 Loan Agreement”) with Mr.

Rosan, pursuant to which the Company was to be indebted in the amount of $2,400,000,

of which $1,200,000 was funded by September 30, 2019 and $1,200,000 was exchanged from the May 2016 Rosen Loan Agreement dated

May 26, 2016 in favor of Rosen for a joint and several interest in the Term Loan pursuant to the Debt Exchange Agreement.

2019 Loan Agreement, the June 2019 Loan bears interest at a rate of 12.5% per annum, compounded annually and payable on the maturity

date of December 3, 2019 (the “June 2019 Maturity Date”) at which time all outstanding principal, accrued and unpaid

interest and other amounts due under the June 2019.

In connection with the conversion of the May 2016 Rosen Loan Agreement the

Company recorded a debt discount of $92,752.

The debt discount is being accreted over the life of the note to accretion of debt

discount and issuance cost.

August 2019 Schiller Loan Agreement

On August 6, 2019, the Company entered into a loan agreement

(the “August 2019 Schiller Loan Agreement”) with Mr.

Schiller, whereby the Company issued a promissory note to Mr.

Schiller in the principal amount of $15,000 (the “August 2019 Schiller Note”).

Pursuant to the August 2019 Schiller

Loan Agreement, the August 2019 Schiller Note bears interest at a rate of $750 per month.

As additional consideration for entering

in the August 2019 Schiller Loan Agreement, the Company issued a five-year warrant to purchase 225 shares of the Company’s

common stock at a purchase price of $6.00 per share.

the year ended December 31, 2019 the Company repaid $15,000 in principal and $750 in interest and the loan is no longer outstanding.

September 2019 Schiller Loan Agreement

On September 26, 2019, the Company entered into a loan agreement

(the “September 2019 Schiller Loan Agreement”) with Mr.

Schiller, whereby the Company issued Mr.

Schiller a promissory

note in the principal amount of $50,000 (the “September 2019 Schiller Note”).

Pursuant to the September 2019 Schiller

Loan Agreement, the September 2019 Schiller Note bears interest at a rate of $2,250 per month.

As additional consideration for

entering in the First September 2019 Schiller Loan Agreement, the Company issued Schiller a five-year warrant to purchase 1,000

shares of the Company’s common stock at a purchase price of $6.00 per share.

the year ended December 31, 2019 the Company repaid $50,000 in principal and $2,250 in interest and the loan is no longer outstanding.

October 2019 Frommer Loan Agreement

On October 7, 2019, the Company entered into a loan agreement

(the “October 2019 Frommer Loan Agreement”) with Mr.

Frommer, whereby the Company issued Mr.

Frommer a promissory note

in the principal amount of $10,000 (the “October 2019 Frommer Note”).

Pursuant to the October 2019 Frommer Loan Agreement,

the October 2019 Frommer Note bears interest at a flat rate of $500.

As additional consideration for entering in the October 2019

Frommer Loan Agreement, the Company issued Mr.

Frommer a five-year warrant to purchase 150 shares of the Company’s common

stock at a purchase price of $6.00 per share.

the year ended December 31, 2019 the Company repaid $10,000 in principal and $225 in interest and the loan is no longer outstanding.

Principal Accountant Fees and Services.

following table sets forth the aggregate fees billed for each of the last two fiscal years for professional services rendered

by the principal accountant for the audit of the Company’s annual financial statements and review of financial statements

included in the Company’s quarterly reports or services that are normally provided by the accountant in connection with

statutory and regulatory filings or engagements for those fiscal years.

Audit-Related Fees

All Other Fees

EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

1 unchanged sentence

exhibits listed below are filed as a part of this annual report.

and Plan of Merger dated February 5, 2016 by and among the Company, GPH Merger Sub., Inc., and Jerrick Ventures, Inc.

(incorporated

by reference to Exhibit 2.1 of the Company’s current report on Form 8-K filed with the Commission on February 11, 2016).

and Plan of Merger dated February 28, 2016 by and among the Company and Jerrick Ventures, Inc.

(incorporated by reference

to Exhibit 2.1 of the Company’s current report on Form 8-K filed with the Commission on March 3, 2016).

Agreement and Plan of Merger dated February 5, 2016 by and among the Company, GPH Merger Sub., Inc., and Jerrick Ventures, Inc.

(incorporated by reference to Exhibit 2.1 of the Company’s current report on Form 8-K filed with the Commission on February 11, 2016).

Agreement and Plan of Merger dated February 28, 2016 by and among the Company and Jerrick Ventures, Inc.

(incorporated by reference to Exhibit 2.1 of the Company’s current report on Form 8-K filed with the Commission on March 3, 2016).

Articles of Incorporation, filed with the Nevada Secretary of State on December 30, 1999 (incorporated by reference to the Company’s annual report on Form 10-SB filed with the Commission on March 30, 2006).

and Restated Articles of Incorporation, filed with the Nevada Secretary of State on November 6, 2013 (incorporated by reference

to Exhibit 3.3 to the Company’s current report on Form 8-K filed with the Commission on December 4, 2013).

of Designation, Preferences, and Rights of Series A Preferred Stock (incorporated by reference to Exhibit 3.1 to the Company’s

current report on Form 8-K filed with the Commission on April 8, 2014).

of Designation, Preferences and Rights of Series B Preferred Stock (incorporated by reference to Exhibit 3.1 of the Company’s

current report on Form 8-K filed with the Commission on December 4, 2014).

of Designation of Series C Preferred Stock (incorporated by reference to Exhibit 3.1 of the Company’s current report

on Form 8-K filed with the Commission on August 3, 2015).

of Designation of Series D Preferred Stock (incorporated by reference to Exhibit 3.1(f) of the Company’s current report

on Form 8-K filed with the Commission on February 11, 2016).

Ventures, Inc.

Amended and Restated Articles of Incorporation, filed with the Nevada Secretary of State on November 6, 2013 (incorporated by reference to Exhibit 3.3 to the Company’s current report on Form 8-K filed with the Commission on December 4, 2013).

Certificate of Designation, Preferences, and Rights of Series A Preferred Stock (incorporated by reference to Exhibit 3.1 to the Company’s current report on Form 8-K filed with the Commission on April 8, 2014).

Certificate of Designation, Preferences and Rights of Series B Preferred Stock (incorporated by reference to Exhibit 3.1 of the Company’s current report on Form 8-K filed with the Commission on December 4, 2014).

Certificate of Designation of Series C Preferred Stock (incorporated by reference to Exhibit 3.1 of the Company’s current report on Form 8-K filed with the Commission on August 3, 2015).

Certificate of Designation of Series D Preferred Stock (incorporated by reference to Exhibit 3.1(f) of the Company’s current report on Form 8-K filed with the Commission on February 11, 2016).

Jerrick Ventures, Inc.

Certificate of Designation of Series A Cumulative Convertible Preferred Stock.

(incorporated by reference

to Exhibit 3.1(f) of the Company’s current report on Form 8-K filed with the Commission on February 11, 2016).

Ventures, Inc.

(incorporated by reference to Exhibit 3.1(f) of the Company’s current report on Form 8-K filed with the Commission on February 11, 2016).

Jerrick Ventures, Inc.

Amendment to Certificate of Designation of Series A Cumulative Convertible Preferred Stock.

(incorporated

by reference to Exhibit 3.1(f) of the Company’s current report on Form 8-K filed with the Commission on February 11,

Ventures, Inc.

(incorporated by reference to Exhibit 3.1(f) of the Company’s current report on Form 8-K filed with the Commission on February 11, 2016).

Jerrick Ventures, Inc.

Certificate of Designation of Series B Cumulative Convertible Preferred Stock.

(incorporated by reference

to Exhibit 3.1(f) of the Company’s current report on Form 8-K filed with the Commission on February 11, 2016).

(incorporated by reference to Exhibit 3.1(f) of the Company’s current report on Form 8-K filed with the Commission on February 11, 2016).

Certificate of Withdrawal of Certificate of Designation for Series A Preferred Stock.

9 unchanged sentences

(incorporated by reference to Exhibit 3.3 of the Company’s current report on Form 8-K filed with the Commission on February 11, 2016).

Convertible Promissory Note between the Company and KBM Worldwide, Inc.

dated August 22, 2014 (incorporated by reference to Exhibit 4.1 to the Company’s current report on Form 8-K filed with the Commission on August 26, 2014).

Convertible Promissory Note between the Company and KBM Worldwide, Inc.

dated November 17, 2014 (incorporated by reference to Exhibit 4.1 to the Company’s current report on Form 8-K filed with the Commission on December 2, 2014).

Securities Purchase Agreement between the Company, Bonjoe Gourmet Chips LLC and certain purchasers dated December 10, 2014 (incorporated by reference to Exhibit 4.1 to the Company’s current report on Form 8-K filed with the Commission on December 10, 2014).

Amended and Restated Securities Purchase Agreement between the Company, Bonjoe Gourmet Chips LLC and certain purchasers dated January 30, 2015 (incorporated by reference to Exhibit 4.1 to the Company’s current report on Form 8-K filed with the Commission on February 3, 2015).

Convertible Debenture, dated March 17, 2016 (incorporated by reference to Exhibit 4.5 to the Company’s annual report on Form 10-K filed with the Commission on April 14, 2016).

Secured Promissory Note, dated April 5, 2016 (incorporated by reference to Exhibit 4.6 to the Company’s annual report on Form 10-K filed with the Commission on April 14, 2016).

Form of Warrant.

(incorporated by reference to Exhibit 4.1 to the Company’s quarterly report on Form 10-Q filed with the Commission on August 24, 2016).

Form of Warrant.

(incorporated by reference to Exhibit 4.1 to the Company’s current report on Form 8- K filed with the Commission on March 21, 2017).

Form of Series A Preferred Common Stock Purchase Warrant (incorporated by reference to Exhibit 4.5 the Company’s Registration Statement on Form S-1 filed with the Commission on August 31, 2016)

Form of Series B Preferred Common Stock Purchase Warrant (incorporated by reference to Exhibit 4.6 the Company’s Registration Statement on Form S-1 filed with the Commission on August 31, 2016)

Common Stock Purchase Warrant, dated April 5, 2016 (incorporated by reference to Exhibit 10.15 to the Company’s annual report on Form 10-K filed with the Commission on April 14, 2016).

Form of Warrant (incorporated by reference to Exhibit 4.1 of the Company’s quarterly report on Form 10-Q filed with the Commission on August 24, 2016).

Form of Warrant (incorporated by reference to Exhibit 10.3 of the Company’s current report on Form 8-K filed with the Commission on January 17, 2017).

Form of Warrant (incorporated by reference to Exhibit 4.1 of the Company’s current report on Form 8-K filed with the Commission on March 21, 2017).

Form of Warrant (incorporated by reference to Exhibit 4.1 of the Company’s current report on Form 8-K filed with the Commission on July 21, 2017).

Form of Warrant (incorporated by reference to Exhibit 4.1 of the Company’s current report on Form 8-K filed with the Commission on September 18, 2017)

Form of Warrant (incorporated by reference to Exhibit 4.1 of the Company’s current report on Form 8-K filed with the Commission on January 2, 2018)

Form of Warrant (incorporated by reference to Exhibit 4.1 of the Company’s current report on Form 8-K filed with the Commission on April 2, 2018)

Form of Warrant (incorporated by reference to Exhibit 4.1 of the Company’s current report on Form 8-K filed with the Commission on May 29, 2018)

Form of Purchaser Warrant (incorporated by reference to Exhibit 4.1 of the Company’s current report on Form 8-K filed with the Commission on August 31, 2018)

Form of Incentive Warrant (incorporated by reference to Exhibit 4.2 of the Company’s current report on Form 8-K filed with the Commission on August 31, 2018)

Agreement for the Purchase and Sale of Real Estate between Ashland Holdings, LLC and TD Bank dated October 29, 2013 (Incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed with the Commission on November 1, 2013).

Release Agreement between the Company and George I.

Norman dated August 15, 2014 (incorporated by reference to Exhibit 10.1 to the Company’s current report on Form 8-K filed with the Commission on August 15, 2014).

Securities Purchase Agreement between the Company and KBM Worldwide, Inc.

dated August 22, 2014 (incorporated by reference to Exhibit 10.1 to the Company’s current report on Form 8-K filed with the Commission on August 26, 2014).

Sale and Purchase Agreement between Ashland Holdings, LLC and Jonathon and Jessica Delavan dated October 2, 2014 (incorporated by reference to Exhibit 10.1 to the Company’s current report on Form 8-K filed with the Commission on October 9, 2014).

Securities Purchase Agreement between the Company and KBM Worldwide, Inc.

dated November 17, 2014 (incorporated by reference to Exhibit 10.1 to the Company’s current report on Form 8-K filed with the Commission on December 2, 2014).

Investment Agreement dated as of November 30, 2014 by and between the Company and Kent Campbell (incorporated by reference to Exhibit 10.1 to the Company’s current report on Form 8-K filed with the Commission on December 4, 2014).

Royalty Agreement between the Company and Bonjoe Gourmet Chips LLC dated December 10, 2014 (incorporated by reference to Exhibit 10.1 to the Company’s current report on Form 8-K filed with the Commission on December 16, 2014).

Securities Purchase Agreement dated as of July 29, 2015 between Great Plains Holdings, Inc.

and Cape One Master Fund II LP.

(incorporated by reference to Exhibit 10.1 of the Company’s current report on Form 8-K filed with the Commission on August 3, 2015).

Spin-Off Agreement dated as of February 5, 2016 between the Company and Kent Campbell.

(incorporated by reference to Exhibit 10.9 of the Company’s current report on Form 8-K filed with the Commission on February 11, 2016).

Share Exchange Agreement dated as of February 5, 2016 by and among Great Plains Holdings, Inc., Kent Campbell, Denis Espinoza and Sarah Campbell.

(incorporated by reference to Exhibit 10.10 of the Company’s current report on Form 8-K filed with the Commission on February 11, 2016).

Form of Stock Purchase Agreement.

(incorporated by reference to Exhibit 10.11 of the Company’s current report on Form 8-K filed with the Commission on February 11, 2016).

Loan Agreement by and between the Company and Arthur Rosen, dated May 26, 2016.

(incorporated by reference to Exhibit 10.1 of the Company’s current report on Form 8-K filed with the Commission on June 2, 2016).

Security Agreement by and between the Company and Arthur Rosen, dated May 26, 2016.

(incorporated by reference to Exhibit 10.2 of the Company’s current report on Form 8-K filed with the Commission on June 2, 2016).

Form of Subscription Agreement (incorporated by reference to Exhibit 10.1 to the Company’s quarterly report on Form 10-Q filed with the Commission on August 24, 2016).

Form of Subscription Agreement (incorporated by reference to Exhibit 10.1 to the Company’s current report on Form 8-K filed with the Commission on March 21, 2017).

Form of Promissory Note (incorporated by reference to Exhibit 10.2 to the Company’s current report on Form 8-K filed with the Commission on March 21, 2017).

Form of Subscription Agreement (incorporated by reference to Exhibit 10.1 of the Company’s quarterly report on Form 10-Q filed with the Commission on August 24, 2016).

Assignment and Assumption Agreement, dated May 12, 2017 (incorporated by reference to Exhibit 10.1 of the Company’s quarterly report on Form 10-Q filed with the Commission on May 15, 2017).

Line of Credit Agreement, dated May 9, 2017 by and between the Company and Arthur Rosen (incorporated by reference to Exhibit 10.1 of the Company’s quarterly report on Form 10-Q filed with the Commission on May 15, 2017).

Promissory Note Issued In Favor Grawlin, LLC, Dated May 12, 2017, (incorporated by reference to Exhibit 10.1 of the Company’s quarterly report on Form 10-Q filed with the Commission on May 15, 2017).

Form of Subscription Agreement (incorporated by reference to Exhibit 10.1 of the Company’s current report on Form 8-K filed with the Commission on January 17, 2017).

Form of Promissory Note (incorporated by reference to Exhibit 10.2 of the Company’s current report on Form 8-K filed with the Commission on January 17, 2017).

Form of Subscription Agreement (incorporated by reference to Exhibit 10.1 of the Company’s current report on Form 8-K filed with the Commission on March 21, 2017).

Form of Promissory Note (incorporated by reference to Exhibit 10.2 of the Company’s current report on Form 8-K filed with the Commission on March 21, 2017).

Form of Securities Purchase Agreement (incorporated by reference to Exhibit 10.1 of the Company’s current report on Form 8-K filed with the Commission on July 21, 2017).

Form of 8.5% Convertible Redeemable Debentures due April 18, 2018 (incorporated by reference to Exhibit 10.2 of the Company’s current report on Form 8-K filed with the Commission on July 21, 2017).

Securities Purchase Agreement between the Company and Crossover Capital Fund I, LLC dated July 11, 2017 (incorporated by reference to Exhibit 10.1 of the Company’s current report on Form 8-K filed with the Commission on September 15, 2017)

Jerrick Media Holdings Inc.

8.5% Convertible Redeemable Note Due April 11, 2018 (incorporated by reference to Exhibit 10.2 of the Company’s current report on Form 8-K filed with the Commission on September 15, 2017)

First Amendment to 8.5% Convertible Redeemable Note Due April 11, 2018 (incorporated by reference to Exhibit 10.3 of the Company’s current report on Form 8-K filed with the Commission on September 15, 2017)

Securities Purchase Agreement between the Company and Diamond Rock LLC dated July 24, 2017 (incorporated by reference to Exhibit 10.4 of the Company’s current report on Form 8-K filed with the Commission on September 15, 2017)

Jerrick Media Holdings Inc 8.5% Convertible Redeemable Note Due April 11, 2018 (incorporated by reference to Exhibit 10.5 of the Company’s current report on Form 8-K filed with the Commission on September 15, 2017)

First Amendment to 8.5% Convertible Redeemable Note Due April 24, 2018 (incorporated by reference to Exhibit 10.6 of the Company’s current report on Form 8-K filed with the Commission on September 15, 2017)

First Amendment to 8.5% Convertible Redeemable Note Due April 18, 2018 (incorporated by reference to Exhibit 10.7 of the Company’s current report on Form 8-K filed with the Commission on September 15, 2017)

Form of Subscription Agreement (incorporated by reference to Exhibit 10.1 of the Company’s current report on Form 8-K filed with the Commission on September 18, 2017)

Form of Promissory Note (incorporated by reference to Exhibit 10.2 of the Company’s current report on Form 8-K filed with the Commission on September 18, 2017)

Form of Registration Rights Agreement (incorporated by reference to Exhibit 10.3 of the Company’s current report on Form 8-K filed with the Commission on February 14, 2018)

Form of Subscription Agreement (incorporated by reference to Exhibit 10.1 of the Company’s current report on Form 8-K filed with the Commission on January 2, 2018)

Form of Promissory Note (incorporated by reference to Exhibit 10.2 of the Company’s current report on Form 8-K filed with the Commission on January 2, 2018)

Form of Securities Purchase Agreement (incorporated by reference to Exhibit 10.1 of the Company’s current report on Form 8-K filed with the Commission on February 13, 2018)

Form of Promissory Note (incorporated by reference to Exhibit 10.2 of the Company’s current report on Form 8-K filed with the Commission on February 13, 2018)

Form of Securities Purchase Agreement (incorporated by reference to Exhibit 10.1 of the Company’s current report on Form 8-K filed with the Commission on April 2, 2018)

Form of Promissory Note (incorporated by reference to Exhibit 10.2 of the Company’s current report on Form 8-K filed with the Commission on April 2, 2018)

Form of Securities Purchase Agreement (incorporated by reference to Exhibit 10.1 of the Company’s current report on Form 8-K filed with the Commission on May 29, 2018)

Form of Promissory Note (incorporated by reference to Exhibit 10.2 of the Company’s current report on Form 8-K filed with the Commission on May 29, 2018)

Form of Securities Purchase Agreement (incorporated by reference to Exhibit 10.1 of the Company’s current report on Form 8-K filed with the Commission on August 31, 2018)

Form Registration Rights Agreement (incorporated by reference to Exhibit 10.2 of the Company’s current report on Form 8-K filed with the Commission on August 31, 2018)

Form of Lock-Up Agreement (incorporated by reference to Exhibit 10.3 of the Company’s current report on Form 8-K filed with the Commission on August 31, 2018)

Form of Series A Preferred Stock Conversion Letter Agreement (incorporated by reference to Exhibit 10.4 of the Company’s current report on Form 8-K filed with the Commission on August 31, 2018)

Form of Series B Preferred Stock Conversion Letter Agreement (incorporated by reference to Exhibit 10.5 of the Company’s current report on Form 8-K filed with the Commission on August 31, 2018)

Form of Convertible Note Conversion Letter Agreement (incorporated by reference to Exhibit 10.6 of the Company’s current report on Form 8-K filed with the Commission on August 31, 2018)

Form of Promissory Note Conversion Letter Agreement (incorporated by reference to Exhibit 10.7 of the Company’s current report on Form 8-K filed with the Commission on August 31, 2018)

Lease Agreement (incorporated by reference to Exhibit 10.5 of the Company’s quarterly report on Form 10-Q filed with the Commission on August 20, 2018)

Letter from Sadler, Gibb & Associates, LLC dated January 7, 2019

List of Subsidiaries (incorporated by reference to Exhibit 21.1 of the Company’s Registration Statement on Form S-1 filed with the Commission on October 24, 2018)

Certification of Chief Executive Officer Pursuant to Exchange Act Rule 13a-14(a), As adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Certification of Chief Financial Officer Pursuant to Exchange Act Rule 13a-14(a), As adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Certification of Chief Executive Officer pursuant to 18 U.S.C.

Section 1350, As adopted Pursuant to Section 906 of the Sarbanes-Oxley Act 2002

Certification of Chief Financial Officer pursuant to 18 U.S.C.

Description of Securities Registered Under Section 12 of the

Letter from Sadler, Gibb & Associates, LLC dated January 7, 2019 (incorporated by reference to Exhibit 16.1 of the Company’s current report on Form 8-K filed with the Commission on January 8, 2019)

List of Subsidiaries

Certification of Principal Executive and Financial Officer Pursuant to Exchange Act Rule 13a-14(a), As adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Certification of Principal Executive and Financial Officer pursuant to 18 U.S.C.

Section 1350, As adopted Pursuant to Section 906 of the Sarbanes-Oxley Act 2002

XBRL Instance Document

XBRL Taxonomy Extension Schema

XBRL Taxonomy Extension Calculation Linkbase

XBRL Taxonomy Extension Definition Linkbase

XBRL Taxonomy Extension Label Linkbase

XBRL Taxonomy Extension Presentation Linkbase

Filed herewith

Instance Document

Taxonomy Extension Schema

Taxonomy Extension Calculation Linkbase

Taxonomy Extension Definition Linkbase

Taxonomy Extension Label Linkbase

Taxonomy Extension Presentation Linkbase

Pursuant to the requirements of Section

2 unchanged sentences

JERRICK MEDIA HOLDINGS, INC.

April 1, 2019

March 30, 2020

/s/ Jeremy Frommer

7 unchanged sentences

and on the dates indicated.

/s/ Justin Maury

April 1, 2019

/s/ Jeremy Frommer

Chief Executive Officer, Director

March 30, 2020

( Principal Executive Officer, Principal Financial Officer, and Principal Accounting Officer )

/s/ Leonard Schiller

April 1, 2019

Chairman, Board of Directors

March 30, 2020

Leonard Schiller

/s/ Andrew Taffin

April 1, 2019

Andrew Taffin

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 9A. Controls and Procedures